(1 reference)-
- Target Alle Ig Produkte
- Ig
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Applikation
- ELISA, Western Blotting (WB)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Immunogen
- Normal human IgM and IgG, and human IgM, IgG and IgA paraproteins
- Isotyp
- IgG
-
Goat anti-Human Ig (Chain kappa) antibody (Biotin)
ELISA, FACS, IHC, WB Polyclonal IgG Biotin
Goat anti-Human Ig antibodyELISA, FACS Polyclonal IgG unconjugated F(ab')2 fragment
Goat anti-Human Ig antibody (Biotin)ELISA, FACS Polyclonal IgG Biotin F(ab')2 fragment
Goat anti-Human Ig antibody (FITC)ELISA, FACS Polyclonal IgG FITC F(ab')2 fragment
Goat anti-Human Ig antibody (PE)ELISA, FACS Polyclonal IgG PE F(ab')2 fragment
Goat anti-Human Ig (Chain lambda) antibodyELISA, FACS, IHC, WB Polyclonal IgG unconjugated
Goat anti-Human Ig (Chain lambda) antibody (HRP)ELISA, IHC, WB Polyclonal IgG HRP
Goat anti-Human Ig (Chain lambda) antibody (Biotin)ELISA, FACS, IHC, WB Polyclonal IgG Biotin
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
: "BLT-humanized C57BL/6 Rag2-/-?c-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection." in: Blood, Vol. 122, Issue 25, pp. 4013-20, (2013) (PubMed).
-
: "BLT-humanized C57BL/6 Rag2-/-?c-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection." in: Blood, Vol. 122, Issue 25, pp. 4013-20, (2013) (PubMed).
-
- Target
- Ig
- Abstract
- Ig Produkte
-
Sie sind hier:
